MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.
Similac, Abbott Laboratories' (NYSE:ABT) infant nutrition brand, has launched its "Love Without Measure" initiative. The campaign focuses on easing social media pressures on young and Gen Z parents and promoting a more supportive online community. Similac is partnering with motherhood experts and social media influencers to highlight mental health, inclusivity, and judgment free parenting. For investors following Abbott Laboratories, the move highlights how the company is engaging with...
The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.